Toxoplasmosis in a group of glucose-6-phosphate dehydrogenase deficient patients
Saudi Medical Journal. 2001; 22 (4): 330-332
in English
| IMEMR
| ID: emr-58260
ABSTRACT
This was a retrospective study that aimed at evaluating the relative risk of Toxoplasma infection in patients with glucose-6-phosphate dehydrogenase deficiency as compared to a control group with no glucose-6-phosphate dehydrogenase deficiency. Ninety-one blood donor volunteers had serology testing from Toxoplasma gondii and were screened for glucose-6-phosphate dehydrogenase deficiency by a qualitative method using fluorescent spot test. They were all males and their ages ranged from 17 to 52 years. Fifty-three persons [58%] were glucose-6-phosphate dehydrogenase deficient and 38 [42%] were glucose-6-phosphate dehydrogenase normal. In the glucose-6-phosphate dehydrogenase deficient group, 31 [58.5%] had positive titers for Toxoplasma; while in the glucose-6-phosphate dehydrogenase normal group 9 persons [24%] had positive titers for Toxoplasma. The relative risk of infection was 2.5 times more in the glucose-6-phosphate dehydrogenase deficient group, a statistically significant difference with a p value of 0.002. Glucose-6-phosphate dehydrogenase deficiency seems to increase the risk for Toxoplasma infection by 2.5 fold probably due to decreased killing effect, of phagocytic cells
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Pentose Phosphate Pathway
/
Toxoplasma
/
Enzyme-Linked Immunosorbent Assay
/
Serologic Tests
/
Epidemiologic Studies
/
Toxoplasmosis
/
Neutrophils
Type of study:
Controlled clinical trial
Limits:
Humans
/
Male
Language:
English
Journal:
Saudi Med. J.
Year:
2001
Similar
MEDLINE
...
LILACS
LIS